A large body of preclinical research has confirmed that in experimental stroke models, VNS can significantly reduce infarct volume, lower the levels of pro-inflammatory cytokines (e.g., TNF-α, IL-6) in serum and brain tissue, and improve neurological outcomes (127). Here, IL6 is linked to stroke disorder.